Insider Holders & Insider Ownership - Catalent Inc. (CTLT)

List of insiders holdings for Catalent Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
# Insider Holder Name Report
Date Time		 Shares Owned
Directly
Indirectly		 Total
Shares Owned		 Filing
1 Zippelius Peter
Director		 2022-10-31 17:46:24 11,979
4,330,462		 4,342,441 Form 4
2 Chiminski John R
Executive Chair		 2022-08-26 20:16:30 229,888
0		 229,888 Form 4
3 WALSH MATTHEW M
EVP & Chief Financial Officer		 2017-08-28 12:29:43 103,703
0		 103,703 Form 4
4 Joseph Wetteny
SVP & Chief Financial Officer		 2021-02-18 09:56:20 79,227
0		 79,227 Form 4
5 Johnson Sharon
See Remarks		 2017-04-27 11:02:19 77,645
0		 77,645 Form 4
6 Fasman Steven L
EVP & Chief Admin Officer		 2023-12-12 19:11:23 75,423
0		 75,423 Form 4/A
7 Leonard Stephen
See Remarks		 2016-07-28 19:21:12 73,140
0		 73,140 Form 4
8 Arnold Jonathan
SVP, CCO & Div. Head BioP Del.		 2023-12-12 18:58:20 57,573
0		 57,573 Form 4/A
9 Kurt Nielsen
See Remarks		 2015-02-19 19:28:35 57,156
0		 57,156 Form 4/A
10 Dolan Christine
SVP - Product Development		 2017-08-31 10:41:26 53,736
0		 53,736 Form 4
11 Miyamoto Lance
SVP, Human Resources		 2019-03-11 19:31:14 46,799
0		 46,799 Form 4
12 Downie William
SVP, Global Sales & Marketing		 2019-02-20 15:48:52 46,662
0		 46,662 Form 4
13 BUZY PETER L
President, Gene Therapy		 2020-04-13 12:12:26 45,950
0		 45,950 Form 4
14 Littlejohns Barry
President, Biologics & SDD		 2019-08-26 15:49:32 45,882
0		 45,882 Form 4
15 Pravda Ricardo
Chief Transformation Officer		 2023-12-12 19:21:40 30,982
0		 30,982 Form 4/A
16 Balachandran Madhavan
Director		 2023-10-31 17:07:40 27,441
0		 27,441 Form 4
17 Grippo Michael J
SVP, Strategy & Corp. Dev.		 2023-12-12 19:05:25 25,229
0		 25,229 Form 4/A
18 Flynn Karen
Director		 2023-10-31 17:00:54 24,339
0		 24,339 Form 4
19 Crane Rosemary A
Director		 2023-10-31 17:02:08 23,873
0		 23,873 Form 4
20 QUELLA JAMES
Director		 2017-08-28 11:31:48 20,641
0		 20,641 Form 4
21 Castellano Thomas P
SVP, Chief Financial Officer		 2022-08-26 20:16:03 20,099
0		 20,099 Form 4
22 Kreuzburg Christa
Director		 2024-01-29 16:09:05 18,283
0		 18,283 Form 4
23 Schmidt Kay A
SVP, Enterprise Functions		 2022-08-26 20:23:59 17,388
0		 17,388 Form 4
24 BOOTH MELVIN D
Director		 2016-08-26 14:56:50 16,665
0		 16,665 Form 4
25 Roehrhoff Uwe
Director		 2017-11-22 16:25:28 16,489
0		 16,489 Form 4
26 Houlton Scott
See Remarks		 2015-09-04 17:39:27 16,380
0		 16,380 Form 4
27 Zayas Ricardo
SVP, Operations, Biologics NA		 2023-08-03 17:17:23 16,101
0		 16,101 Form 4
28 Boerman Manja
Pres. BioModalities Division		 2023-05-03 19:00:37 14,414
0		 14,414 Form 4
29 HEGWOOD PAUL W JR
President, CSS		 2019-08-26 15:48:26 11,848
0		 11,848 Form 4
30 Lickfold Charles
SVP, CIO		 2023-12-12 19:19:54 11,719
0		 11,719 Form 4/A
31 Hunt Patricia
Pres. Consumer Health Div		 2023-12-12 19:17:51 11,501
0		 11,501 Form 4/A
32 Santiago Karen Murphy
VP & Chief Accounting Officer		 2023-08-03 17:21:21 9,979
0		 9,979 Form 4
33 Carletti Lorenzo
SVP Global Ops Ph & Cons Hlth		 2023-12-12 19:09:14 9,178
0		 9,178 Form 4/A
34 Hawkeswood Thomas W
Pres. Pharma Prod Delivery Div		 2023-12-12 19:16:02 7,827
0		 7,827 Form 4/A
35 Riley Michael A.
Pres. Bio Product Delivery Div		 2022-08-30 14:38:01 6,592
0		 6,592 Form 4
36 Gargiulo Mario
SVP, Ops, Biologics Europe		 2023-05-03 18:58:00 5,676
0		 5,676 Form 4
37 Whitlow Ricci S
President, CSS		 2022-01-24 16:42:46 2,923
0		 2,923 Form 4
38 Ryan Michelle R
Director		 2024-12-18 13:18:04 0
0		 0 Form 4
39 DAMELIO FRANK A
Director		 2024-12-18 13:01:55 0
0		 0 Form 4
40 Okey Stephanie
Director		 2024-12-18 13:08:55 0
0		 0 Form 4
41 MOREL DONALD E JR
Director		 2024-12-18 13:06:47 0
0		 0 Form 4
42 LUCIER GREGORY T
Director		 2024-12-18 13:04:16 0
0		 0 Form 4
43 Gennadios Aristippos
Group Pres. Pharma & Consumer		 2024-12-18 14:10:11 0
0		 0 Form 4
44 STAHL JACK L
Director		 2024-12-18 13:20:34 0
0		 0 Form 4
45 Ferraro Joseph Anthony
SVP, General Counsel, CCO		 2024-12-18 13:56:18 0
0		 0 Form 4
46 Gunther Scott
SVP, Quality & Reg. Affairs		 2024-12-18 14:00:41 0
0		 0 Form 4
47 Hatzfeld Michael
Chief Accounting Officer		 2024-12-18 14:05:24 0
0		 0 Form 4
48 McErlane David
Group President, Biologics		 2024-12-18 14:07:42 0
0		 0 Form 4
49 McEvoy Bruce
Director		 2014-07-31 20:19:30 0
0		 0 Form 3
50 CLASSON ROLF A
Director		 2024-12-18 12:59:21 0
0		 0 Form 4
51 CARROLL J MARTIN
Director		 2024-12-18 12:57:08 0
0		 0 Form 4
52 Barg Steven
Director		 2024-12-18 12:55:33 0
0		 0 Form 4
53 Barber Michael J
Director		 2024-12-18 12:52:22 0
0		 0 Form 4
54 Maselli Alessandro
President & CEO		 2024-12-18 11:13:00 0
0		 0 Form 4
55 Hopson Ricky
Pres. BioProduct Delivery, CoS		 2024-12-18 11:12:48 0
0		 0 Form 4
56 Masanovich Matti
SVP, Chief Financial Officer		 2024-12-18 11:12:23 0
0		 0 Form 4
57 GREISCH JOHN J
Executive Chair		 2024-12-18 11:12:08 0
0		 0 Form 4
58 Evoli Lisa
SVP, Chief HR Officer		 2024-12-18 11:11:39 0
0		 0 Form 4
59 Blackstone Management Associates V L.L.C.
Blackstone Healthcare Partners L.L.C.
BLACKSTONE CAPITAL PARTNERS V L P
BMA V L.L.C.
Blackstone Holdings III L.P.
Blackstone Holdings III GP L.P.
Blackstone Holdings III GP Management L.L.C.
Blackstone Group L.P.
Blackstone Group Management L.L.C.
SCHWARZMAN STEPHEN A
10% Owner		 2017-02-14 14:25:56 0
0		 0 Form 13G
60 Chu Chinh
Director		 2014-07-31 20:29:59 0
0		 0 Form 3